| Epidemiology from Literature | | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | | 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 0.000 | 20120528, Patelis A
| | 1.3 - Rhinitis, Diagnosed | 2013 | Brazil | IgE | 101 | 0.000 | 20130912, Lacerda Araujo LM
| | 1.5 - Atopic Dermatitis, Diagnosed | 2013 | Austria | IgE | 15 | 0.000 | 20131216, Baar A
| | 1.5 - Atopic Dermatitis, Diagnosed | 2013 | Germany | IgE | 140 | 0.710 | 20130111, Ott H
| | 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 0.000 | 20091005, Ott H
| | 1.6 - Anaphylaxis, Diagnosed | 2013 | Japan | IgE | 36 | 50.000 | 20130424, Kohno K
| | 1.9 - Pollen Allergy | 2012 | France | IgE | 10 | 10.000 | 20121030, Mameri H
| | 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 9.000 | 20110223, De Knop KJ
| | 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 0.000 | 20091121, Ebo DG
| | 10.1 - Normal Control | 2012 | France | IgE | 12 | 8.330 | 20121030, Mameri H
| | 3.2.1 - Source Sensitized (IgE) | 2012 | Japan | IgE | 138 | 24.640 | 20120103, Ebisawa M
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 0.000 | 20091121, Ebo DG
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2011 | Germany | IgE | 10 | 0.000 | 20110511, Sander I
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2013 | Austria | IgE | 14 | 14.280 | 20131216, Baar A
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 0.000 | 20091121, Ebo DG
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 0.000 | 20090826, Ebo DG
| | 5.2.4 - Source Exposed, Adults (Symptoms, IgE) | 2013 | Austria | IgE | 37 | 51.350 | 20131216, Baar A
| | 5.2.4 - Source Exposed, Adults (Symptoms, IgE) | 2012 | France | IgE | 21 | 57.140 | 20121030, Mameri H
| | 5.2.5 - Source Exposed, Children (Symptoms, IgE) | 2012 | France | IgE | 82 | 45.120 | 20121030, Mameri H
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 1.010 | 20110223, De Knop KJ
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Japan | IgE | 173 | 72.250 | 20120103, Ebisawa M
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Japan | IgE | 54 | 79.600 | 20121024, Chinuki Y
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Japan | IgE | 30 | 6.600 | 20121024, Chinuki Y
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2010 | Japan | IgE | 23 | 100.000 | 20101124, Fukutomi Y
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2011 | Korea, Republic of | IgE | 17 | 100.000 | 20111011, Park HJ
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2012 | Austria / Italy | IgE | 29 | 6.900 | 20120123, Pahr S
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2009 | France | IgE | 24 | 66.660 | 20081126, Jacquenet S
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2012 | Germany | IgE | 17 | 82.350 | 20120917, Hofmann SC
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2008 | Japan | IgE | 50 | 80.000 | 20080104, Matsuo H
| | 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 0.000 | 20120528, Patelis A
| | 6.5 - Occupational Exposure | 2012 | France | IgE | 29 | 13.790 | 20121030, Mameri H
| | 6.5 - Occupational Exposure | 2011 | Germany | IgE | 40 | 2.500 | 20110511, Sander I
| | 6.5 - Occupational Exposure | 2013 | Italy | IgE | 51 | 0.000 | 20130520, Olivieri M
|
|
Loading...
Tri a 19
